Virus-host cell interactions in vaccine production cell lines infected with different human influenza A virus variants: A proteomic approach

Journal of Proteomics

Volumn 73, Issue 9, 2010, Pages 1656-1669

  Vester, Diana ^a   Rapp, Erdmann ^b   Kluge, Sabine ^b   Genzel, Yvonne ^b   Reichl, Udo ^a,b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR DYNAMICS OF COMPLEX TECHNICAL SYSTEMS   (Germany)

Author keywords

2 D DIGE; Antiviral response; Cell culture engineering; Influenza A virus; LC MS MS; Vaccine production cell lines

Indexed keywords

INTERFERON; PROTEOME; CYTOSKELETON PROTEIN; HEAT SHOCK PROTEIN; INFLUENZA VACCINE; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL STRAIN; CONTROLLED STUDY; HEAT SHOCK; INFLUENZA VIRUS A; INTERFERON PRODUCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEOMICS; SIGNAL TRANSDUCTION; VACCINE PRODUCTION; VERO CELL; VIRUS CELL INTERACTION; VIRUS REPLICATION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL LINE; CHLOROCEBUS AETHIOPS; DOG; GENE EXPRESSION PROFILING; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; KIDNEY; PHYSIOLOGY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VERO CELL LINE; VIROLOGY;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; CYTOSKELETAL PROTEINS; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION PROFILING; HEAT-SHOCK PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; KIDNEY; PROTEOME; SIGNAL TRANSDUCTION; VERO CELLS; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 77954657137     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2010.04.006     Document Type: Article

References (59)

1. Genzel Y., Reichl U. Vaccine production - state of the art and future needs in upstream processing. Methods in biotechnology: animal cell biotechnology - methods and protocols 2007, 457-473. Humana Press Inc, Totowa, New Jersey. R. Pörtner (Ed.).
2. Walsh G. Biopharmaceutical benchmarks 2006. Nat Biotechnol 2006, 24:769-776.
3. WHO Cell culture as a substrate for the production of influenza vaccines: memorandum from a WHO meeting. Bull World Health Organ 1995, 73:431-435.
4. Genzel Y., Behrendt I., Koenig S., Sann H., Reichl U. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture. Vaccine 2004, 22:2002-2008.
5. Tree J.A., Richardson C., Fooks A.R., Clegg J.C., Looby D. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains. Vaccine 2001, 19:3444-3450.
6. Montagnon B.J., Fanget B., Nicholas A.J. The large scale cultivation of Vero cells in microcarrier culture for virus vaccine production. Preliminary results for killed poliovirus vaccine. Dev Biol Stand 1981, 47:56-64.
7. Kistner O., Barrett P.N., Mundt W., Reiter M., Schober-Bendixen S., et al. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine. Vaccine 1998, 16:960-968.
8. Youil R., Su Q., Toner T.J., Szymkowiak C., Kawn W.S., Rubin B., et al. Comparative study of influenza virus replication in Vero and MDCK cell lines. J Virol Methods 2004, 120:23-31.
9. Doroshenko A., Halperin S.A. Trivalent MDCK cell culture-derived influenza vaccine Optaflu® (Novartis Vaccines). Expert Rev Vaccines 2009, 8:679-688.
10. Pau M.G., Ophorst C., Koldijk M.H., Schouten G., Mehtali M., Uytdehaag F. The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. Vaccine 2001, 19:2716-2721.
11. Sandig V., Jordan I. Immortalized avian cell lines for virus production. Germany 2005, [30.11.2004].
12. Hornickova Z. Different progress of MDCK cell death after infection by two different influenza virus isolates. Cell Biochem Funct 1997, 15:87-93.
13. Diaz M.O., Ziemin S., Le Beau M.M., Pitha P., Smith S.D., Chilcote R.R., et al. Homozygous deletion of alpha- and beta-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA 1988, 85:5259-5263.
14. Govorkova E.A., Kaverin N.V., Gubareva L.V., Meignier B., Webster R.G. Replication of influenza A viruses in a green monkey kidney continuous cell line (Vero). J Infect Dis 1995, 172:250-253.
15. Ozaki H., Govorkova E.A., Li C., Xiong X., Webster R.G., Webby R.J. Generation of high-yielding influenza A virus in african green monkey kidney (Vero) cells by reverse genetics. J Virol 2004, 78:1851-1857.
16. Görg A., Weiss W., Dunn M.J. Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4:3665-3685.
17. Vester D., Rapp E., Gade D., Genzel Y., Reichl U. Quantitative analysis of cellular proteome alterations in human influenza A virus infected mammalian cell lines. Proteomics 2009, 9:3316-3327.
18. Liu N., Song W., Wang P., Lee K., Chan W., Chen H., et al. Proteomics analysis of differential expression of cellular proteins in response to avian H9N2 virus infection in human cells. Proteomics 2008, 8:1851-1858.
19. Baas T., Baskin C.R., Diamond D.L., García-Sastre A., Bielefeldt-Ohmann H., Tumpey T.M., et al. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J Virol 2006, 21:10813-10828.
20. Shaw M.L., Stone K.L., Colangelo C.M., Gulcicek E.E., Palese P. Cellular proteins in influenza virus particles. PLoS Pathog 2008, 4:e1000085.
21. Gerdil C. The annual production cycle for influenza vaccine. Vaccine 2003, 21:1776-1779.
22. Schulze-Horsel J., Schulze M., Agalaridis G., Genzel Y., Reichl U. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production - flow cytometry and mathematical modeling. Vaccine 2009, 27:2712-2722.
23. Bradford M.M.A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
24. Perkins D.N., Pappin D.J., Creasy D.M., Cottrell J.S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20:3551-3567.
25. Haller O., Staeheli P., Kochs G. Interferon-induced Mx proteins in antiviral host defense. Biochimie 2007, 89:812-818.
26. Hoffmann H.H., Palese P., Shaw M.L. Modulation of influenza virus replication by alteration of sodium ion transport. Antiviral Res 2008, 80:124-134.
27. Radtke K., Dohner K., Sodeik B. Viral interactions with the cytoskeleton: a hitchhiker's guide to the cell. Cell Microbiol 2006, 8:387-400.
28. Sun X., Whittaker G.R. Role of the actin cytoskeleton during influenza virus internalization into polarized epithelial cells. Cell Microbiol 2007, 9:1672-1682.
29. Simpson-Holley M., Ellis D., Fisher D., Elton D., McCauley J., Digard P. A functional link between the actin cytoskeleton and lipid rafts during budding of filamentous influenza virions. Virology 2002, 301:212-225.
30. Arcangeletti M.C., Pinardi F., Missorini S., De Conto F., Conti G., Portincasa P., et al. Modification of cytoskeleton and prosome networks in relation to protein synthesis in influenza A virus-infected LLC-MK2 cells. Virus Res 1997, 51:19-34.
31. Avalos R.T., Yu Z., Nayak D.P. Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J Virol 1997, 71:2947-2958.
32. Mayer D., Molawi K., Martinez-Sobrido L., Ghanem A., Thomas S., Baginsky S., et al. Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J Proteome Res 2007, 6:672-682.
33. Schauber C., Chen L., Tongaonkar P., Vega I., Lambertson D., Potts W., et al. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 1998, 391:715-718.
34. Coux O., Tanaka K., Goldberg A.L. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996, 65:801-847.
35. Hale B.G., Randall R.E., Ortin J., Jackson D. The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008, 89:2359-2376.
36. Kochs G., Garcia-Sastre A., Martinez-Sobrido L.J. Multiple anti-interferon actions of the influenza A virus NS1 protein. J Virol 2007, 81:7011-7021.
37. Krug R.M., Yuan W., Noah D.L., Latham A.G. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 2003, 309:181-189.
38. Simionescu M., Gafencu A., Antohe F. Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microsc Res Tech 2002, 57:269-288.
39. Derry M.C., Sutherland M.R., Restall C.M., Waisman D.M., Pryzdial E.L. Annexin 2-mediated enhancement of cytomegalovirus infection opposes inhibition by annexin 1 or annexin 5. J Gen Virol 2007, 88:19-27.
40. Jacob R., Heine M., Eikemeyer J., Frerker N., Zimmer K.P., Rescher U., et al. Annexin II is required for apical transport in polarized epithelial cells. J Biol Chem 2004, 279:3680-3684.
41. Iannello A., Debbeche O., Martin E., Attalah L.H., Samarani S., Ahmad A. Viral strategies for evading antiviral cellular immune responses of the host. J Leukoc Biol 2006, 79:16-35.
42. Ludwig S., Pleschka S., Planz O., Wolff T. Ringing the alarm bells: signalling and apoptosis in influenza virus infected cells. Cell Microbiol 2006, 8:375-386.
43. Hayman A., Comely S., Lackenby A., Murphy S., McCauley J., Goodbourn S., et al. Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. Virology 2006, 347:52-64.
44. van der Flier A., Sonnenberg A. Function and interactions of integrins. Cell Tissue Res 2001, 305:285-298.
45. Lafrenie R.M., Yamada K.M. Integrin-dependent signal transduction. J Cell Biochem 1996, 61:543-553.
46. + effector T cells from apoptosis during influenza infection. J Immun 2007, 179:5054-5063.
47. Santoro M.G. Heat shock factors and the control of the stress response. Biochem Pharmacol 2000, 59:55-63.
48. Santoro M.G. Viral infection. EXS 1996, 77:337-357.
49. Naito T., Momose F., Kawaguchi A., Nagata K. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits. J Virol 2007, 81:1339-1349.
50. Watanabe K., Fuse T., Asano I., Tsukahara F., Maru Y., Nagata K., et al. Identification of Hsc70 as an influenza virus matrix protein (M1) binding factor involved in the virus life cycle. FEBS Lett 2006, 580:5785-5790.
51. Ciocca D.R., Oesterreich S., Chamness G.C., McGuire W.L., Fuqua S.A. Biological and clinical implications of heat shock protein 27,000 (Hsp27): a review. J Nat Cancer Inst 1993, 85:1558-1570.
52. Ogino T., Yamadera T., Nonaka T., Imajoh-Ohmi S., Mizumoto K. Enolase, a cellular glycolytic enzyme, is required for efficient transcription of Sendai virus genome. Biochem Biophys Res Commun 2001, 285:447-455.
53. Choudhary S., De B.P., Banerjee A.K. Specific phosphorylated forms of glyceraldehyde 3-phosphate dehydrogenase associate with human parainfluenza virus type 3 and inhibit viral transcription in vitro. J Virol 2000, 74:3634-3641.
54. Choi A.M., Knobil K., Otterbein S.L., Eastman D.A., Jacoby D.B. Oxidant stress responses in influenza virus pneumonia: gene expression and transcription factor activation. Am J Physiol 1996, 271:383-391.
55. Chew T., Noyce R., Collins S.E., Hancock M.H., Mossman K.L. Characterization of the interferon regulatory factor 3-mediated antiviral response in a cell line deficient for IFN production. Mol Immunol 2009, 46:393-399.
56. Zhirnov O.P., Konakova T.E., Wolff T., Klenk H.D. NS1 protein of influenza A virus down-regulates apoptosis. J Virol 2002, 76:1617-1625.
57. Ozaki H., Kida H. Extensive accumulation of influenza virus NS1 protein in the nuclei causes effective viral growth in Vero cells. Microbiol Immunol 2007, 51:577-580.
58. Schwarzer J., Rapp E., Hennig R., Genzel Y., Jordan I., Sandig V., et al. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Vaccine 2009, 27:4325-4336.
59. Seitz C., Frensing T., Hoper D., Kochs G., Reichl U. High yields of Influenza A virus in MDCK cells are promoted by an insufficient IFN-induced antiviral state. J Gen Virol 2010, 91:1754-1763.